Loading...
European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice
BACKGROUND: Despite the benefits biosimilars offer in terms of cost savings and patient access, healthcare professionals and patients have been reluctant to use them. Next to insufficient understanding of and trust in biosimilars, healthcare professionals and patients have questions about switching...
Na minha lista:
| Udgivet i: | BioDrugs |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7669768/ https://ncbi.nlm.nih.gov/pubmed/33063267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-020-00440-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|